Literature DB >> 3230426

Liver structure and function in print workers exposed to toluene.

P Guzelian1, S Mills, H J Fallon.   

Abstract

An unresolved controversy is whether exposure to organic solvents in the workplace causes hepatotoxicity. From a medical surveillance study of 289 printing factory employees who were exposed primarily to toluene, we identified eight workers who had persistently abnormal serum transaminase and/or alkaline phosphatase values. The eight men were generally healthy and gave no history of taking medications or of drinking ethanol to excess. None was obese or diabetic. Six patients had hepatomegaly based on physical examination. All eight had mild elevations (less than 2 to 3 times the upper value of normal) of serum transaminases [alanine (ALT) and aspartate aminotransferase (AST)]. However, there was a marked increase in the ratio of ALT/AST (mean = 1.61). In each case, liver biopsy revealed mild, pericentral fatty change. Our results, consistent with those previously published by some others, suggest that pericentral fatty liver with mild "reactive hepatitis" is the most likely diagnosis in workers exposed to solvents for whom common causes of mild liver test abnormalities have been excluded. An increased ALT/AST ratio may represent a convenient, previously unrecognized indicator of this condition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3230426     DOI: 10.1097/00043764-198810000-00008

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  11 in total

Review 1.  Toxic hepatitis in occupational exposure to solvents.

Authors:  Giulia Malaguarnera; Emanuela Cataudella; Maria Giordano; Giuseppe Nunnari; Giuseppe Chisari; Mariano Malaguarnera
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

2.  Kinetic studies on toluene metabolism in ethanol- and phenobarbital-induced rat liver microsomes in vitro.

Authors:  R S Wang; T Nakajima
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  A fatal case of acute hepatitis B developed in a toluene abuser.

Authors:  Hideaki Kato; Jun Monma-Ohtaki; Makoto Nakamura; Yuji Nishi; Makoto Ohyama; Yoshitaka Maeno; Yoshimi Seko-Nakamura; Saeko Nagao; Masataka Nagao
Journal:  Clin J Gastroenterol       Date:  2008-05-16

4.  Structural basis of human pregnane X receptor activation by the hops constituent colupulone.

Authors:  Denise G Teotico; Jason J Bischof; Li Peng; Steven A Kliewer; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2008-09-02       Impact factor: 4.436

5.  Effects of ethanol and phenobarbital treatments on the pharmacokinetics of toluene in rats.

Authors:  R S Wang; T Nakajima
Journal:  Br J Ind Med       Date:  1992-02

6.  Symptoms and signs in workers exposed predominantly to xylenes.

Authors:  Y Uchida; H Nakatsuka; H Ukai; T Watanabe; Y T Liu; M Y Huang; Y L Wang; F Z Zhu; H Yin; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

7.  Results of common laboratory tests in solvent-exposed workers.

Authors:  Ari Kaukiainen; Tapio Vehmas; Kaarina Rantala; Markku Nurminen; Rami Martikainen; Helena Taskinen
Journal:  Int Arch Occup Environ Health       Date:  2003-11-05       Impact factor: 3.015

Review 8.  Toxicant-associated steatohepatitis.

Authors:  Banrida Wahlang; Juliane I Beier; Heather B Clair; Heather J Bellis-Jones; K Cameron Falkner; Craig J McClain; Matt C Cave
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

9.  Effects of occupational exposure to 1,4-dichlorobenzene on hematologic, kidney, and liver functions.

Authors:  Pao-Kuei Hsiao; Yi-Chang Lin; Tung-Sheng Shih; Yin-Mei Chiung
Journal:  Int Arch Occup Environ Health       Date:  2009-02-27       Impact factor: 3.015

10.  Hepatic ultrasonic changes in workers exposed to perchloroethylene.

Authors:  C A Brodkin; W Daniell; H Checkoway; D Echeverria; J Johnson; K Wang; R Sohaey; D Green; C Redlich; D Gretch
Journal:  Occup Environ Med       Date:  1995-10       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.